Floatz logo

Therapeutic Asset Ratings

128 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Benadryl
Follicular Lymphoma
M.D. Anderson Cancer CenterP2CCC (52)
FENTANYL
Follicular Lymphoma
M.D. Anderson Cancer CenterP2CCC (52)
HYDROMORPHON
Follicular Lymphoma
M.D. Anderson Cancer CenterP2CCC (52)
Ketorolac Tromethamine
Follicular Lymphoma
M.D. Anderson Cancer CenterP2CCC (52)
Nemtabrutinib
Follicular Lymphoma
Merck Sharp & Dohme LLCP2CCC (52)
Pirtobrutinib
Follicular Lymphoma
University of WashingtonP2CCC (52)
Zilovertamab Vedotin
Follicular Lymphoma
Merck Sharp & Dohme LLCP2CCC (52)
Allopurinol
Follicular Lymphoma
Masonic Cancer Center, University of MinnesotaP2CCC (51)
Thiotepa
Follicular Lymphoma
Fred Hutchinson Cancer CenterP2CCC (51)
mln9708
Follicular Lymphoma
University of WashingtonP2CCC (50)
Umbralisib
Follicular Lymphoma
City of Hope Medical CenterP2/3CCC (50)
Loncastuximab Tesirine
Follicular Lymphoma
Universität MünsterP2CCC (49)
[18F]F-RESCA-R8B4
Follicular Lymphoma
RenJi HospitalP2CCC (48)
[18F]F-RESCA-RCCB6
Follicular Lymphoma
RenJi HospitalP2CCC (48)
[18F]F-RESCA-RD06
Follicular Lymphoma
RenJi HospitalP2CCC (48)
[68ga]ga-nota-r8b4
Follicular Lymphoma
RenJi HospitalP2CCC (48)
[68ga]ga-nota-rd06
Follicular Lymphoma
RenJi HospitalP2CCC (48)
Abexinostat
Follicular Lymphoma
Xynomic Pharmaceuticals, Inc.P2CCC (48)
Conjugated Pneumococcal Vaccine
Follicular Lymphoma
H. Lee Moffitt Cancer Center and Research InstituteP2CCC (48)
Copanlisib
Follicular Lymphoma
Columbia UniversityP2CCC (48)
Emapalumab
Follicular Lymphoma
Marcela V. Maus, M.D.,Ph.D.P2CCC (48)
Glofitamab
Follicular Lymphoma
Reid Merryman, MDP2CCC (48)
Jwcar029
Follicular Lymphoma
Sun Yat-sen UniversityP2CCC (48)
Linperlisib
Follicular Lymphoma
The First Affiliated Hospital of Xiamen UniversityP2CCC (48)
Orelabrutinib
Follicular Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP2CCC (48)
Showing 51 to 75 of 128 assets
PreviousPage 3 of 6Next